TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29274949

Group type: EXPERIMENTAL
Intervention: Habituation of eating desires
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Violation of overeating expectancies
Number of subjects: 52

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both cue exposure conditions
Number of subjects: 52
Study: 26690319

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (DP-EES)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 407
Study: 24447187

Group type: EXPERIMENTAL
Intervention: Individualized streetside training
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Training in a virtual pedestrian environment
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Videos and websites training
Number of subjects: 231

Group type: COMPARATOR
Intervention: No-training control
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: All training groups (including control)
Number of subjects: 231
Study: 22633601

Group type: EXPERIMENTAL
Intervention: Low-fat diet (20% energy from fat)
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 48835
Study: 20338292

Group type: EXPERIMENTAL
Intervention: Very-low-carbohydrate diet (4% total energy as carbohydrate, 35% protein, 61% fat)
Number of subjects: 68

Group type: COMPARATOR
Intervention: High-carbohydrate diet (46% total energy as carbohydrate, 24% protein, 30% fat)
Number of subjects: 68
Study: 18390558

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation radiation therapy (2.4 Gy/fr)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Conventional fractionation radiation therapy (2 Gy/fr)
Number of subjects: 360
Study: 15988102

Group type: COMPARATOR
Intervention: cilostazol + aspirin (C group)
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: ticlopidine + aspirin (T group)
Number of subjects: 642
Study: 12820029

Group type: EXPERIMENTAL
Intervention: Sutureless Lichtenstein (group 2)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Classical Lichtenstein (group 1)
Number of subjects: 46
Study: 10774681

Group type: EXPERIMENTAL
Intervention: Combination regimens of artemether/pyrimethamine (1‐, 2‐ and 3‐day regimens)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline plasma PYR concentrations
Number of subjects: 0
Study: 8724908

Group type: EXPERIMENTAL
Intervention: Sung lyrics (musical accompaniment)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Read aloud lyrics (no musical accompaniment)
Number of subjects: 20
Study: 1649863

Group type: EXPERIMENTAL
Intervention: Weight reduction and sodium restriction (diet group)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Atenolol (antihypertensive drug treatment group)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 61
Study: 6858934

Group type: EXPERIMENTAL
Intervention: Pirmenol (50 mg priming bolus over 2 minutes, followed by 2.5 mg/min for 1 hour, and 0.25 mg/min maintenance infusion)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pirmenol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study: 31405799

Group type: EXPERIMENTAL
Intervention: Struggle-First (SF) condition
Number of subjects: 42

Group type: COMPARATOR
Intervention: Teach-First (TF) condition
Number of subjects: 42
Study: 29166695

Group type: EXPERIMENTAL
Intervention: Direct Spitzy suture in children
Number of subjects: 476

Group type: COMPARATOR
Intervention: Direct suture in adults (control group)
Number of subjects: 476
Study: 27957632

Group type: EXPERIMENTAL
Intervention: Antiepileptic drug (AED) treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-AED treatment (Control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of patients with subcortical calcifications (AED treatment)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Subgroup analysis of patients with subcortical calcifications (Control)
Number of subjects: 42
Study: 26821625

Group type: EXPERIMENTAL
Intervention: Chlorthalidone, 6.25 mg daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: HCTZ, 12.5 mg daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: HCTZ-CR, 12.5 mg daily
Number of subjects: 54
Study: 24555925

Group type: EXPERIMENTAL
Intervention: 42 °C warm water for 20 min
Number of subjects: 27

Group type: COMPARATOR
Intervention: 15 °C cold water for 20 min
Number of subjects: 27

Group type: COMPARATOR
Intervention: Baseline condition at room temperature
Number of subjects: 27
Study: 23405799

Group type: EXPERIMENTAL
Intervention: Yangjing Capsule (5 pills, tid) plus low-dose tadalafil (5 mg, qd, 1 h before bedtime)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Oral ephedrine (25 mg before bedtime)
Number of subjects: 55
Study: 19580356

Group type: EXPERIMENTAL
Intervention: Teleassistance system using real-time transmission of blood glucose results and telephone consultations
Number of subjects: 328

Group type: COMPARATOR
Intervention: Regular follow-up at healthcare center (Control)
Number of subjects: 328
Study: 17503670

Group type: EXPERIMENTAL
Intervention: 1 mg/kg Suc-HSA (single dose)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10 mg/kg Suc-HSA (single dose)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10 mg/kg Suc-HSA (multiple doses)
Number of subjects: 10

Group type: COMPARATOR
Intervention: N/A (control not specified)
Number of subjects: 10
Study: 15613683

Group type: COMPARATOR
Intervention: Old volunteers
Number of subjects: 22
Study: 12470517

Group type: EXPERIMENTAL
Intervention: 585 nm laser treatment at subpurpura energy level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second treatment with 585 nm laser 2 weeks later
Number of subjects: 0

Group type: COMPARATOR
Intervention: Broadband, pulsed, white light source at 4 J/cm(2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Broadband, pulsed, white light source at 7 J/cm(2)
Number of subjects: 0
Study: 9638854

Group type: EXPERIMENTAL
Intervention: Low-dose ATG (total dose 484 +/- 110 mg, 0.75 mg/kg per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-dose OKT3 (total dose 32 +/- 4 mg, 0.05 mg/kg per day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-dose ATG
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-dose OKT3
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both ATG and OKT3
Number of subjects: 60
Study: 7990322

Group type: EXPERIMENTAL
Intervention: Cryosurgical debridement
Number of subjects: 0
Study: 2648839

Group type: EXPERIMENTAL
Intervention: 1.5 gm of calcium supplementation a day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 29803204

Group type: EXPERIMENTAL
Intervention: Moderate eccentric cadence (REG) 2/0/2/0
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Slow eccentric cadence (SLOW) 6/0/2/0
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both protocols (SLOW and REG)
Number of subjects: 16
Study: 28162127

Group type: EXPERIMENTAL
Intervention: Monthly food voucher of $US 40
Number of subjects: 4343

Group type: EXPERIMENTAL
Intervention: Monthly food voucher of $US 40 plus training on health and nutrition
Number of subjects: 4343

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4343
Study: 25119510

Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection into the long posterior sacroiliac ligament
Number of subjects: 34

Group type: COMPARATOR
Intervention: Isotonic saline injection on the contralateral side
Number of subjects: 34
Study: 23117188

Group type: EXPERIMENTAL
Intervention: Roflumilast (500 μg once daily)
Number of subjects: 3091

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3091
Study: 22085683

Group type: EXPERIMENTAL
Intervention: Acupuncture alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture as an adjunct to pharmacotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacotherapy alone
Number of subjects: 0
Study: 19062151

Group type: EXPERIMENTAL
Intervention: One‐Step (OS) adhesive at 55 degrees C
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Clearfil S3 Bond (S3) adhesive at 55 degrees C
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (SE) adhesive at 55 degrees C
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: All‐Bond 2 (AB) adhesive at 55 degrees C
Number of subjects: 28

Group type: COMPARATOR
Intervention: Temperature effect on water sorption and solubility
Number of subjects: 28
Study: 16505654

Group type: EXPERIMENTAL
Intervention: Hygroscopic heat-and-moisture exchanger (HME)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Hot-water humidification with a heater wire (DHW)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Inspiratory limb only (SHW)
Number of subjects: 381

Group type: COMPARATOR
Intervention: HME
Number of subjects: 381

Group type: COMPARATOR
Intervention: All groups (HME, DHW, SHW)
Number of subjects: 381
Study: 12753491

Group type: EXPERIMENTAL
Intervention: Training group (n = 18) using the non-dominant leg for 8 weeks during soccer training
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (n = 21)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Training group (n = 18)
Number of subjects: 39
Study: 11134834

Group type: EXPERIMENTAL
Intervention: Dietary sodium restriction
Number of subjects: 88

Group type: COMPARATOR
Intervention: Ad libitum sodium intake
Number of subjects: 88
Study: 9715427

Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg for the first week, 50 mg for the second week, and 75 mg nightly thereafter for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8602901

Group type: EXPERIMENTAL
Intervention: Xylitol/sorbitol chewing gum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Xylitol-containing gum (stick and pellet forms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorbitol gum
Number of subjects: 0
Study: 2737169

Group type: EXPERIMENTAL
Intervention: Sip-feed supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-compliant patients (who failed to receive supplements)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supplemented patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unsupplemented patients
Number of subjects: 0
Study: 30990792

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise (40% to 60% of heart rate reserve) for 8 weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard medical care, education for foot care, and diet (control group)
Number of subjects: 87
Study: 29048185

Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification (CBM)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Impulsivity measured by Barratt Impulsiveness Scale (BIS)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Impulsivity measured by Experiential Discounting Task (EDT)
Number of subjects: 125
Study: 25261385

Group type: EXPERIMENTAL
Intervention: Elastic band exercises (40 minutes, 3 times per week for 6 months)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 127
Study: 23490008

Group type: EXPERIMENTAL
Intervention: Monopolar transurethral resection of the prostate (M‐TURP)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Bipolar transurethral resection of the prostate (B‐TURP)
Number of subjects: 295
Study: 21683321

Group type: EXPERIMENTAL
Intervention: AMR101 4 g/day
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: AMR101 2 g/day
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: AMR101 4 g/day (baseline TG >750 mg/dl)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: AMR101 2 g/day (baseline TG >750 mg/dl)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: AMR101
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study: 19390542

Group type: EXPERIMENTAL
Intervention: losartan 50 mg/HCTZ 12.5 mg (titrated to losartan 100 mg/HCTZ 12.5 mg at 4 weeks and losartan 100 mg/HCTZ 25 mg at 8 weeks)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: losartan 50 mg/HCTZ 12.5 mg
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: losartan/HCTZ combination therapy
Number of subjects: 430
Study: 16887481

Group type: EXPERIMENTAL
Intervention: Left thoracoabdominal approach (LTA)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Abdominal-transhiatal approach (TH)
Number of subjects: 167
Study: 15572179

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 and 2 mg on two successive days)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 11263603

Group type: EXPERIMENTAL
Intervention: Gamma irradiation (192Ir)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 9413769

Group type: EXPERIMENTAL
Intervention: Chronic renal failure (CRF) patients
Number of subjects: 0
Study: 8351862

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg/day)
Number of subjects: 51
Study: 29800131

Group type: EXPERIMENTAL
Intervention: Real-time model-generated personalized melanoma risk assessment and tailored melanoma-prevention advice
Number of subjects: 272

Group type: COMPARATOR
Intervention: Generic melanoma-prevention advice
Number of subjects: 272
Study: 27600795

Group type: EXPERIMENTAL
Intervention: Omacor® 4 g/day
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Omacor® 2 g/day
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 26068602

Group type: EXPERIMENTAL
Intervention: UFT/LV (tegafur-uracil with leucovorin) administered at 300 mg/m²/day with 75 mg/day for 5 courses (5 weeks each)
Number of subjects: 1720

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1720
Study: 23800669

Group type: EXPERIMENTAL
Intervention: Surgery 4-7 days after last fraction of radiotherapy
Number of subjects: 1242

Group type: COMPARATOR
Intervention: Surgery 0-3 days after last fraction of radiotherapy
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy
Number of subjects: 1242

Group type: COMPARATOR
Intervention: Interval groups comparison
Number of subjects: 1242
Study: 21804100

Group type: EXPERIMENTAL
Intervention: Two fixed-dose combination tablets (ibuprofen 400 mg/paracetamol 1000 mg)
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: One fixed-dose combination tablet (ibuprofen 200 mg/paracetamol 500 mg)
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: One combination tablet (ibuprofen 200 mg/paracetamol 500 mg)
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Two combination tablets (ibuprofen 400 mg/paracetamol 1000 mg)
Number of subjects: 892

Group type: COMPARATOR
Intervention: Paracetamol (1000 mg)
Number of subjects: 892

Group type: COMPARATOR
Intervention: Ibuprofen (400 mg)
Number of subjects: 892
Study: 19165707

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Botulinum toxin B
Number of subjects: 30

Group type: COMPARATOR
Intervention: Botulinum toxin A or B
Number of subjects: 30
Study: 17206894

Group type: EXPERIMENTAL
Intervention: Tubeless PCNL with supracostal access
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group with routine nephrostomy tube placement
Number of subjects: 72
Study: 12962764

Group type: EXPERIMENTAL
Intervention: Dual-drug therapy (tacrolimus and corticosteroids)
Number of subjects: 475

Group type: COMPARATOR
Intervention: Triple-drug therapy (tacrolimus, azathioprine, and corticosteroids)
Number of subjects: 475
Study: 11236241

Group type: EXPERIMENTAL
Intervention: Positive exercise test (group I, 78 patients)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Negative exercise test (group II, 165 patients)
Number of subjects: 243
Study: 8621832

Group type: EXPERIMENTAL
Intervention: UVB radiation
Number of subjects: 1

Group type: COMPARATOR
Intervention: UVA radiation
Number of subjects: 1

Group type: COMPARATOR
Intervention: Combination UVB/UVA phototherapy
Number of subjects: 1

Group type: COMPARATOR
Intervention: Heat associated with phototherapy
Number of subjects: 1
Study: 1458618

Group type: EXPERIMENTAL
Intervention: 4% lignocaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 50
Study: 6530538

Group type: EXPERIMENTAL
Intervention: Low sodium diet (50 mmol daily)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High sodium diet (300 mmol daily)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous frusemide administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular sodium intake
Number of subjects: 20
Study: 30659039

Group type: EXPERIMENTAL
Intervention: Daily intake of refined wheat bread enriched with 6 g of wheat germ
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (non-enriched bread)
Number of subjects: 55
Study: 30078420

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 209

Group type: COMPARATOR
Intervention: Headphone group
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 209
Study: 25808921

Group type: EXPERIMENTAL
Intervention: Neuropsychological assessment using reliable change confidence intervals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patient-matched healthy controls
Number of subjects: 0
Study: 25205802

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Pooled cohort (TAVR, n=220; standard therapy, n=229)
Number of subjects: 449
Study: 22828688

Group type: EXPERIMENTAL
Intervention: 10 mg bupivacaine 0.5% plus 5 μg dexmedetomidine (dexmedetomidine group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 10 mg bupivacaine 0.5% plus 5 μg dexmedetomidine and 25 μg fentanyl (dexmedetomidine= group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 10 mg bupivacaine 0.5% (control group)
Number of subjects: 90
Study: 20131980

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% shampoo (CP shampoo)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 168
Study: 17105818

Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT)
Number of subjects: 2090

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2090
Study: 15942752

Group type: EXPERIMENTAL
Intervention: High-resolution three-dimensional magnetic resonance imaging (MRI) of the vestibular organ
Number of subjects: 0
Study: 12486428

Group type: EXPERIMENTAL
Intervention: 5 mg rosuvastatin
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin
Number of subjects: 477

Group type: COMPARATOR
Intervention: 20 mg pravastatin
Number of subjects: 477

Group type: COMPARATOR
Intervention: 20 mg simvastatin
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: rosuvastatin (5 mg and 10 mg)
Number of subjects: 477

Group type: COMPARATOR
Intervention: pravastatin
Number of subjects: 477

Group type: COMPARATOR
Intervention: simvastatin
Number of subjects: 477
Study: 9578099

Group type: EXPERIMENTAL
Intervention: Viscoped insoles
Number of subjects: 33

Group type: COMPARATOR
Intervention: Langer insoles
Number of subjects: 33
Study: 8133086

Group type: EXPERIMENTAL
Intervention: Combination therapy with zidovudine and didanosine (ddI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Zidovudine only
Number of subjects: 50

Group type: COMPARATOR
Intervention: Didanosine (ddI) only
Number of subjects: 50
Study: 2546026

Group type: EXPERIMENTAL
Intervention: N‐methylformamide (N‐MF)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Spirogermanium
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 4‐demethoxydaunorubicin
Number of subjects: 144
Study: 241115

Group type: EXPERIMENTAL
Intervention: Sucrose-containing iron medicines
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 50% aqueous sucrose solution
Number of subjects: 6

Group type: COMPARATOR
Intervention: Iron medicines with sorbitol
Number of subjects: 6
Study: 31816169

Group type: EXPERIMENTAL
Intervention: LA + DCB
Number of subjects: 117

Group type: COMPARATOR
Intervention: LA + BA
Number of subjects: 117
Study: 31118099

Group type: EXPERIMENTAL
Intervention: Prednisone (PDN) alone
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Prednisone (PDN) + Methotrexate (MTX)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Prednisone (PDN) + Cyclosporine (CSA)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Reference group (PDN discontinued)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Overall treatment outcomes
Number of subjects: 139
Study: 27918724

Group type: EXPERIMENTAL
Intervention: telotristat ethyl 250 mg
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: telotristat ethyl 500 mg
Number of subjects: 135

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: telotristat ethyl 250 mg and 500 mg
Number of subjects: 135
Study: 25479736

Group type: EXPERIMENTAL
Intervention: Active tPCS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 24165068

Group type: EXPERIMENTAL
Intervention: Touch massage
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Touch massage and Control group
Number of subjects: 20
Study: 22074836

Group type: EXPERIMENTAL
Intervention: Surgical removal of the mucosa covering retained teeth
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no treatment, only observation)
Number of subjects: 40
Study: 19715434

Group type: EXPERIMENTAL
Intervention: GaAlAs laser
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3% potassium oxalate gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 30
Study: 16924983

Group type: EXPERIMENTAL
Intervention: Etch & rinse systems (Single Bond; SB and Scotchbond Multi‐Purpose Plus; SBMP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self‐etch systems (Clearfil SE Bond; SE, Optibond Solo Plus Self‐Etch Primer; SO, Tyrian Self Priming Etchant + One Step Plus; TY)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3-step etch & rinse system
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self‐etching adhesive systems
Number of subjects: 30
Study: 15176128

Group type: EXPERIMENTAL
Intervention: Complex aural stimuli
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Tempo and sound volume level of aural stimuli
Number of subjects: 11

Group type: COMPARATOR
Intervention: No-stimulus
Number of subjects: 11